Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand.

Authors :: Byrnes C.A.
Kolbe J.
Maclennan C.
McDonald M.
Morris P.
Nicolson C.
Petsky H.
Pillarisetti N.
Reynolds E.
Serisier D.
Thein F.
van Asperen P.
Voss L.
Wong C.
Chang A.B.
Bell S.C.
Torzillo P.J.
Alison J.
King P.T.
Maguire G.P.
Holland A.E.
O'Mara P.
Grimwood K.
Cull C.
Currie B.
Gardner I.
Holmes P.
Hunter C.
Byrnes C.A.
Kolbe J.
Maclennan C.
McDonald M.
Morris P.
Nicolson C.
Petsky H.
Pillarisetti N.
Reynolds E.
Serisier D.
Thein F.
van Asperen P.
Voss L.
Wong C.
Chang A.B.
Bell S.C.
Torzillo P.J.
Alison J.
King P.T.
Maguire G.P.
Holland A.E.
O'Mara P.
Grimwood K.
Cull C.
Currie B.
Gardner I.
Holmes P.
Hunter C.
Publication Year :: 2016
Abstract: Guidelines on managing chronic suppurative lung disease (CSLD) and bronchiectasis (unrelated to cystic fi brosis [CF]) in Australian Indigenous children initiated in 20021 were extended to include Indigenous adults in 20082 and children and adults living in urban areas of Australia and New Zealand in 2010.3 Here, we present an updated guideline relevant for all sections of the community. The recommendations in this guideline are targeted principally to primary and secondary care, and are not intended for individualised specialist care. As with all guidelines, they are not a substitute for sound clinical judgement, particularly when investigating and treating such a phenotypically heterogeneous condition as bronchiectasis.Copyright © 2015, Australasian Medical Publishing Co. Ltd. All rights reserved.

Tools